San Jose, CA, United States of America

Lin Peng

This inventor holds 1 USPTO granted patent. Top assignee: Oculex Pharmaceuticals, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lin Peng. Retrieved from https://idiyas.com/inventor/lin-peng-varbfg3s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 210(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lin Peng: Pioneering Inventor from San Jose

Introduction: Lin Peng is a distinguished inventor based in San Jose, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Lin Peng holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Lin Peng has worked with leading tech companies in Silicon Valley, where he has played a key role in developing cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, Lin Peng has collaborated with top researchers, engineers, and scientists to bring innovative ideas to life. His collaborative spirit has led to the successful implementation of numerous projects and inventions.

Conclusion: Lin Peng's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the tech industry. His work continues to inspire future generations of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…